Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid Tumors
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase I trial is studying the side effects and best dose of flavopiridol when given
together with gemcitabine and irinotecan in treating patients with unresectable or metastatic
solid tumors. Drugs used in chemotherapy, such as flavopiridol, gemcitabine, and irinotecan,
work in different ways to stop tumor cells from dividing so they stop growing or die.
Combining more than one drug may kill more tumor cells